BioLife Solutions BLFS Debt Securities, Available-for-sale, Amortized Cost, Noncurrent
Debt Securities, Available-for-sale, Amortized Cost, Noncurrent at other companies
Other financials
Where this comes from
Reported directly by BioLife Solutions in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent.
The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioLife Solutions's debt securities, available-for-sale, amortized cost, noncurrent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is BioLife Solutions's debt securities, available-for-sale, amortized cost, noncurrent?
- BioLife Solutions (BLFS) reported debt securities, available-for-sale, amortized cost, noncurrent of $30.6M in Q1 2026.
- How has BioLife Solutions's debt securities, available-for-sale, amortized cost, noncurrent changed year-over-year?
- BioLife Solutions's debt securities, available-for-sale, amortized cost, noncurrent increased by 60.7% year-over-year, from $19.04M to $30.6M.